Recruiting

Evaluating the Implementation of a Comprehensive Multilevel Virtual Oncology Program Among Veterans Diagnosed With Lung, Colorectal, Prostate, and Breast Cancers in the US Department of Veterans Affairs

The objective of the pragmatic trial to test the effectiveness of an existing, ongoing clinical service, the VA National TeleOncology program (NTO), a multilevel telehealth population health management program. The primary aims are to study the intervention and determine its effectiveness on telehealth engagement, clinical quality, and healthcare cost outcomes across personal characteristics.

ClinicalTrials.gov IDNCT06559059

PhaseNA

Enrollment1800

SponsorNYU Langone Health

Age18 Years and older

SexALL

I'm interested View official listing

Conditions studied

Lung Cancer Diagnosis, Colorectal Cancer (Diagnosis), Prostate Cancer Diagnosis, Breast Cancer Diagnosis

About this study

Interventions

Behavioral: National TeleOncology — Medical and/or subspecialty oncology care offered via facility-to-facility telehealth as an alternative to usual in-person care at the nearest VA or community oncology care setting offering similar services.

Primary outcomes

Number of raw telehealth visits (Post-NTO implementation (up to 3 months))
Fraction of patients engaging in at least one telehealth visit (Post-NTO implementation (up to 3 months))

Eligibility information

Patients Inclusion Criteria: 1. A Veteran 2. Aged 18 years or older 3. Newly diagnosed with lung, prostate, breast, or colon cancer within 3 months of telemedicine visit 4. Engaged in an oncology visit during the 36-month analysis period at a Veterans Affairs Medical Center (VAMC) location. VAMC Providers and Staff Inclusion Criteria: 1. Provider or staff member at one of the VAMC locations including physicians, nurse practitioners, physicians' assistants, and nurses caring for Veterans 2. Providers or staff members having helped provide care for at least 5 Veterans with cancer in the previous 6 months at a VAMC location Patients Exclusion Criteria: 1. Veterans who have not seen any providers in the VA within the past year 2. Patients previously diagnosed with lung, prostate, breast, or colon cancer 3. Pregnant patients VAMC Providers and Staff Exclusion Criteria: 1\. Providers or staff members who do not help treat Veterans with specified cancers in oncology at the VA

Study locations

VA New York Harbor Healthcare System - Brooklyn, Brooklyn, New York 11209 United States
VA New York Harbor Healthcare System - St. Albans Community Living Center, Jamaica, New York 11425 United States
VA New York Harbor Health Care System - Manhattan, New York, New York 10010 United States
VA New York Harbor Healthcare System - Harlem Community Center, New York, New York 10027 United States
VA New York Harbor Healthcare System - Staten Island Community Clinic, Staten Island, New York 10314 United States

Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.

Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-10-19.